XZXiaolan Zhu

Xiaolan Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaolan Zhu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The predictive value of renal parenchymal information for renal function impairment in patients with ADPKD: a multicenter prospective study

    by Yuhang Xie, Mengmiao Xu, Yajie Chen, Xiaolan Zhu, Shenghong Ju, Yuefeng Li

    Objective Although the guideline indicates that total kidney volume (TKV) is an important detection indicator in patients with autosomal dominant polycystic kidney disease (ADPKD), this study attempted to demonstrate that renal parenchymal information, combined with parenchymal volume and radiomics features, may have more valuable clinical guiding significance. Methods A totals of 340 ADPKD patients with normal renal function were prospectively collected and followed-up for five years, with renal function tests and non-contrast computed tomography (CT) performed every six months. The relationship between renal function impairment and renal parenchymal volume (RPV) as along with radiomics features was explored using a multiple linear regression model and multiple logistic regression. Then, a combined model of RPV with radiomics features was constructed to comprehensively evaluate its predictive value. Results Compared with TKV, decreased RPV presented a closer relationship with renal function impairment, namely, with the impairment rate (RPV: 82.3% vs. TVK: 67.1%) and eGFR (RPV: r = 0.614, p < 0.001 vs. TKV: r = -0.452, p < 0.001), and showed higher predictive power (RPV: AUC = 0.752 [95%CI 0.692–0.805], p < 0.001 vs. TKV: AUC = 0.711 [95%CI 0.649–0.768], p < 0.001). Correspondingly, the radiomics analysis that was derived from the renal parenchyma also showed a satisfactory result (AUC = 0.849 [95%Cl 0.797–0.892], p < 0.001). Importantly, the predictive power for renal function impairment was further improved in the combined model of RPV and radiomics features (AUC = 0.902 [95%Cl 0.857–0.937], p < 0.001). Conclusion Renal parenchyma information may be a sensitive biomarker of renal function impairment in ADPKD, which can provide a new approach for clinically monitoring renal function, and may greatly improve the pre-hospital prevention and treatment effects. Graphical abstract


  • Top Cited Papers
    Open Access

    Neuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression

    by Xian Xian, Li-Li Cai, Yang Li, Ran-Chao Wang, Yu-Hao Xu, Ya-Jie Chen, Yu-Hang Xie, Xiao-Lan Zhu, Yue-Feng Li

    Background: Neuroinflammation is an important component mechanism in the development of depression. Exosomal transfer of MDD-associated microRNAs (miRNAs) from neurons to microglia might exacerbate neuronal cell inflammatory injury. Results: By sequence identification, we found significantly higher miR-9-5p expression levels in serum exosomes from MDD patients than healthy control (HC) subjects. Then, in cultured cell model, we observed that BV2 microglial cells internalized PC12 neuron cell-derived exosomes while successfully transferring miR-9-5p. MiR-9-5p promoted M1 polarization in microglia and led to over releasing of proinflammatory cytokines, such as interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which exacerbated neurological damage. Furthermore, we identified suppressor of cytokine signaling 2 (SOCS2) as a direct target of miR-9-5p. Overexpression of miR-9-5p suppressed SOCS2 expression and reactivated SOCS2-repressed Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) pathways. Consistently, we confirmed that adeno-associated virus (AAV)-mediated overexpression of miR-9-5p polarized microglia toward the M1 phenotype and exacerbated depressive symptoms in chronic unpredictable mild stress (CUMS) mouse mode. Conclusion: MiR-9-5p was transferred from neurons to microglia in an exosomal way, leading to M1 polarization of microglia and further neuronal injury. The expression and secretion of miR-9-5p might be novel therapeutic targets for MDD. Graphical


  • Increased ASL-CBF in the right amygdala predicts the first onset of depression in healthy young first-degree relatives of patients with major depression

    by Ningning Zhang, Jiasheng Qin, Jinchuan Yan, Yan Zhu, Yuhao Xu, Xiaolan Zhu, Shenghong Ju, Yuefeng Li

    Healthy first-degree relatives of patients with major depression are at an elevated risk of developing depression, and regional cerebral blood flow (CBF) alterations are observed in patients with depression. Therefore, in a 33-month follow-up study, we used arterial spin labeling-magnetic resonance imaging (ASL-MRI) to investigate quantitative CBF before and after the diagnosis of depression in healthy young adults with and without first-degree relatives with major depression (FH + and FH−, respectively). In cross-sectional and longitudinal CBF comparisons, CBF in the right amygdala was increased or decreased. Additionally, a significant correlation was observed between the altered CBF in the right amygdala and the scores on the 17-item Hamilton Depression Rating Scale (HDRS) in the FH + group. Furthermore, logistic regression and receiver operating characteristic curve analyses showed that increased CBF in the right amygdala at baseline predicted the subsequent onset of depression in the FH + group. Our results suggest that among healthy young adults with a familial risk of depression, those who exhibit increased CBF in the amygdala are susceptible to developing this disease.


  • Increased hippocampal fissure width is a sensitive indicator of rat hippocampal atrophy

    by Yuefeng Li, Jinchuan Yan, Xiaolan Zhu, Yan Zhu, Jiasheng Qin, Ningning Zhang, Shenghong Ju


  • Fibroblast growth factor 22 is a novel modulator of depression through interleukin‐1β

    by Yu‐Hao Xu, Ming Yu, Hong Wei, Shun Yao, Si‐Yuan Chen, Xiao‐Lan Zhu, Yue‐Feng Li

    Summary: Background and Aims: Emerging evidence shows that fibroblast growth factor 22 (FGF22) plays a critical role in the etiology of depression. However, the molecular mechanisms of FGF22 are not fully comprehended. Here, the effect of FGF22 in depression and its relationship with interleukin‐1β (IL‐1β) were investigated in clinical, animal, and cell experiments.Methods: Serum from depressive patients was collected, and the levels of FGF22 and IL‐1β were analyzed by ELISA. The chronic unpredictable mild stress (CUMS) model was established, and primary hippocampal neuronal cells were cultured to examine changes in FGF22 and IL‐1β levels in rat hippocampus.Results: The results revealed a negative correlation between serum FGF22 levels and serum IL‐1β levels. The expression of IL‐1β in the CUMS rat hippocampus decreased, and the apoptosis of hippocampal cells improved after the injection of lentiviral vector‐mediated FGF22 (LV‐FGF22). Further tests in primary hippocampal neuronal cells also showed a reduction in IL‐1β and the cell apoptosis rate after treatment with FGF22.Conclusion: In conclusion, the results revealed that FGF22 plays a role in alleviating depression, which may be mediated by reduced expression of IL‐1β.